Skip to main content
Fig. 3 | Hereditas

Fig. 3

From: Huanglian-Hongqu herb pair improves nonalcoholic fatty liver disease via NF-κB/NLRP3 pathway in mice: network pharmacology, molecular docking and experimental validation

Fig. 3

Binding mode of nine high-peak compounds with NF-κB, NLRP3, ASC, and Caspase-1. (A) Coptisine with NF-κB. (B) Berberine with NF-κB. (C) Epiberberine with NF-κB. (D) Palmatine with NF-κB. (E) Quercetin with NF-κB. (F) Berberine with NLRP3. (G) Quercetin with NLRP3. (H) Coptisine with ASC. (I) Berberine with ASC

Back to article page